9 results
Prostanoid prescribing and management in Pulmonary Arterial Hypertension (PAH)
Oral Prostanoids:
 - Selexipag
 - Treprostinil
Inhaled Prostanoids
 -
in Pulmonary Arterial ... Hypertension (PAH ... #PAH #Management ... #Algorithm #treatment ... #pharmacology
Treatment Algorithm for Pulmonary Hypertension

#Pulmonary #Hypertension #PAH #Treatment #Management #Algorithm #Medications
Treatment Algorithm ... for Pulmonary Hypertension ... #Pulmonary # ... Hypertension #PAH ... #Treatment #Management
Low / Intermediate Risk Pulmonary Arterial Hypertension (PAH) Management Algorithm

Dr. John Ryan @JJRyanMD

#Pulmonary #Arterial #Hypertension #PAH
(PAH) Management ... Algorithm Dr. ... #PAH #Management ... #Algorithm #treatment ... #pharmacology
High Risk Pulmonary Arterial Hypertension (PAH) Management Algorithm

Dr. John Ryan @JJRyanMD

#Pulmonary #Arterial #Hypertension #PAH #Management #Algorithm
High Risk Pulmonary ... (PAH) Management ... Algorithm Dr. ... #PAH #Management ... #Algorithm #treatment
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Algorithm for Chronic ... hospitalization or emergency ... #COPD #Treatment ... #Algorithm #Management ... SABA #SAMA #ICS #Pharmacology
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... algorithms by Global ... indicate preferred treatment ... #Management #Pulmonary ... #COPD #GOLD2017
An Algorithm for the Management of Seizures

The management of active seizures is algorithmic, starting with a
the Management ... Seizures The management ... and bag-valve mask ... Pharmacologic treatment ... #Management #Emergency
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
with presence of pulmonary ... #differential #algorithm ... #management #cardiology ... #treatment #table ... icu #clinical #pharmacology
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
amyloidosis, PAH ... phenomenon (16%) MSK ... Adenocarcinoma Treatment ... lubricants • Pharmacologic ... Rheumatology #Diagnosis #Management